Removal of hepatocarcinoma cells from blood via cell washing and filtration techniques.
Utilization of autotransfusion during tumor resection remains controversial due to viability of carcinoma cells remaining in collected blood. The purpose of this study was to evaluate autotransfusion techniques combined with leukocyte depleting filters (LDF) for removal of hepatocarcinoma cells from autotransfusate. An in vitro model was created by contaminating expired human erythrocytes with cultured hepatocarcinoma (HEP G2) cells. Autotransfusion devices evaluated were Cobe BRAT2, Sorin STAT-P, and Fresenius CATS. Autotransfusate collected from varying processing conditions were filtered using the Pall Leukoguard RS or Pall Purecell RCQ LDF. Carcinoma concentrations were quantified via Coulter Counter technology. The CATS exhibited higher concentrations of cancer cells in the autotransfusate prior to washing, a 449% increase. This was significantly higher than either the BRAT2 or STAT-P, 350% and 315% respectively. Post washing HEP G2 concentrations in the BRAT2 were significantly higher than the STAT-P and CATS. Doubled wash volumes removed more HEP G2 cells in all trials, reaching statistical significance only in the CATS. LDF resulted in a significant 75% reduction of HEP G2 cells, with no difference between filters. While combination use of autotransfusion devices and leukocyte depleting filters did result in a product with concentrated hematocrit, no technique removed all hepatocarcinoma cells.
Division of Clinical Perfusion Education, School of Allied Health Professions, University of Nebraska Medical Center, Omaha.
C C
CC
Jones
A H
AH
Stammers
L W
LW
Fristoe
K T
KT
Jones
D J
DJ
Beck
M L
ML
Pierce
M S
MS
Dickes
D001804:Blood Transfusion, Autologous / Q000295:instrumentation / Q000379:methods; D006528:Carcinoma, Hepatocellular / Q000097:blood* / Q000473:pathology; D002469:Cell Separation; D006440:Hemofiltration / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D008113:Liver Neoplasms / Q000097:blood* / Q000473:pathology; D009360:Neoplastic Cells, Circulating / Q000473:pathology*; D014407:Tumor Cells, Cultured